Core Viewpoint - Halper Sadeh LLC is investigating whether Olaplex Holdings, Inc. is obtaining a fair price for its shareholders in the proposed sale to Henkel AG & Co. KGaA at $2.06 per share [2][4]. Group 1: Investigation Details - The investigation focuses on whether Olaplex and its board violated federal securities laws and fiduciary duties by failing to secure the best price for shareholders, conducting a fair sales process, and disclosing all material information [4]. - Insiders may benefit financially from the transaction in ways not available to ordinary shareholders, raising concerns about potential conflicts of interest [1][4]. Group 2: Shareholder Rights - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their rights and options at no cost, with the firm operating on a contingent fee basis [2][3]. - The firm may seek increased consideration, additional disclosures, or other relief for shareholders [5].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Braskem S.A. due to significant financial losses and concerns regarding compliance with federal securities laws [1][4]. Financial Performance - Braskem disclosed a consolidated net loss of approximately R$10.96 billion for the year 2025 and has accumulated losses of around R$23.9 billion [3]. - The company's independent auditor noted a material uncertainty regarding Braskem's ability to continue as a going concern, indicating severe balance-sheet stress with current liabilities exceeding total assets [3]. Stock Performance - Following the financial disclosures, Braskem's stock experienced a decline, adversely affecting investors [3]. Legal Investigation - Johnson Fistel is examining whether Braskem's executive officers complied with federal securities laws in light of the financial issues disclosed [4].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Veritone, Inc. due to significant losses following the company's disappointing financial disclosures [1][4]. Group 1: Financial Performance - On March 26, 2026, Veritone reported preliminary, unaudited financial results for Q4 and full year 2025, indicating expected revenue between approximately $18.1 million to $30.0 million, which is below the prior guidance of $33.4 million to $39.4 million [3]. - The wide revenue range was attributed to a single, complex non-monetary transaction, with its accounting treatment still subject to final determination, potentially impacting reported revenue [3]. Group 2: Stock Performance and Legal Investigation - Following the financial disclosures, Veritone's stock price declined during trading on March 26, 2026, prompting Johnson Fistel to investigate compliance with federal securities laws [4]. - Investors who suffered losses from their investment in Veritone stock are encouraged to contact Johnson Fistel for potential recovery of losses [2][4]. Group 3: About Johnson Fistel, PLLP - Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with a strong track record, having recovered approximately $90.7 million for clients in cases where it served as lead or co-lead counsel [6]. - The firm represents both individual and institutional investors in shareholder derivative and securities class action lawsuits [5].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Maze Therapeutics, Inc. following a significant stock price decline after the announcement of clinical trial results [1][4]. Group 1: Investigation Details - The investigation focuses on whether Maze's executive officers may have violated federal securities laws, potentially allowing for recovery of investor losses [1][4]. - Investors who purchased Maze securities and suffered losses are encouraged to join the investigation, with no cost or obligation [2]. Group 2: Clinical Trial Results - On March 25, 2026, Maze announced topline results from its Phase 2 HORIZON trial for MZE829, reporting a mean reduction in urine albumin-to-creatinine ratio (uACR) of approximately 35.6% at Week 12, with about 50% of patients achieving over a 30% reduction [3]. - The company characterized these results as "clinically meaningful" and indicative of initial clinical proof-of-concept [3]. Group 3: Stock Price Reaction - Following the announcement of the clinical trial results, Maze's stock price declined by approximately 33% on the same day [4].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Achieve Life Sciences, Inc. due to significant losses following the company's financial disclosures [1][3][4]. Group 1: Investigation Details - The investigation focuses on whether Achieve Life Sciences' executive officers complied with federal securities laws after the company reported continued operating losses and limited cash reserves [3][4]. - Following the financial results announcement on March 24, 2026, Achieve Life Sciences' stock price experienced a significant decline during intraday trading [3]. Group 2: Company Background - Achieve Life Sciences reported its fourth quarter and full-year 2025 financial results, highlighting ongoing operational challenges [3]. - Johnson Fistel, PLLP is a nationally recognized law firm specializing in shareholder rights and securities class action lawsuits, representing both individual and institutional investors [5]. Group 3: Firm Achievements - In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms, recovering approximately $90,725,000 for clients in cases where it served as lead or co-lead counsel [6].

Core Viewpoint - Bernstein Liebhard LLP is investigating potential breaches of fiduciary duties by certain directors and officers of Bath & Body Works, Inc. [1] Group 1: Company Overview - Bath & Body Works, Inc. is publicly traded on the NYSE under the ticker BBWI [1]. - The investigation is focused on the actions of the company's directors and officers regarding their responsibilities to the company [1]. Group 2: Legal Context - Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients since its establishment in 1993 [3]. - The firm has represented both individual investors and large public and private pension funds, indicating a strong reputation in the legal field [3]. - The firm has been recognized multiple times in The National Law Journal's "Plaintiffs' Hot List" and has been listed in The Legal 500 for sixteen consecutive years, showcasing its success in litigation [3].

Core Viewpoint - Halper Sadeh LLC is investigating whether Urgent.ly, Inc. is obtaining a fair price for its shareholders in the proposed sale to Agero, Inc. for $5.50 per share, raising concerns about potential conflicts of interest and fiduciary duty violations by the board of directors [1]. Group 1: Investigation Details - The investigation focuses on whether Urgent.ly and its board violated federal securities laws and/or breached fiduciary duties by failing to obtain the best possible price for shareholders [1]. - Concerns include the lack of a fair sales process free from conflicts of interest and the failure to disclose all material information necessary for shareholders to evaluate the transaction [1]. Group 2: Shareholder Rights - Halper Sadeh LLC encourages Urgent.ly shareholders to contact the firm to discuss their rights and options at no cost, with the possibility of seeking increased consideration or additional disclosures [1]. - The firm operates on a contingent fee basis, meaning shareholders would not be responsible for out-of-pocket legal fees or expenses [1].

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of ASP Isotopes Inc. (NASDAQ: ASPI) towards shareholders [1] Group 1: Investigation Details - The investigation focuses on whether the actions of ASP Isotopes Inc. insiders have harmed shareholder interests [1] - Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation [1] Group 2: Shareholder Rights and Options - Long-term shareholders of ASP Isotopes may seek corporate governance reforms, return of funds, court-approved financial incentives, or other relief [1] - Participation of shareholders is emphasized as a means to improve company policies and enhance shareholder value [1] Group 3: Legal Representation - Halper Sadeh LLC represents investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [1]

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by officers and directors of WM Technology, Inc. (NASDAQ: MAPS), encouraging shareholders to contact the firm to discuss their rights and potential corporate governance reforms [1][1]. Group 1: Company Overview - WM Technology, Inc. is under scrutiny for possible misconduct by its leadership, which may have affected shareholder interests [1]. - The firm offers legal services on a contingent fee basis, meaning shareholders will not incur out-of-pocket expenses for legal fees [1]. Group 2: Shareholder Rights - Long-term shareholders of WM Technology may seek various forms of relief, including corporate governance reforms, financial incentives, or the return of funds to the company [1]. - Shareholder participation is emphasized as a means to enhance company transparency, accountability, and overall management effectiveness, potentially increasing shareholder value [1].

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of New Fortress Energy Inc., encouraging shareholders to contact the firm to discuss their rights and options [1] Group 1: Company Overview - New Fortress Energy Inc. (NASDAQ: NFE) is under scrutiny for possible corporate governance issues, with shareholders being urged to seek reforms and financial incentives [1] - The firm offers its services on a contingent fee basis, meaning shareholders will not incur out-of-pocket legal fees [1] Group 2: Shareholder Rights - Long-term shareholders of New Fortress may have the opportunity to pursue corporate governance reforms, recover funds, or receive court-approved financial awards [1] - Shareholder participation is emphasized as a means to enhance company policies and practices, ultimately improving shareholder value [1] Group 3: Legal Context - Halper Sadeh LLC represents investors globally who have experienced securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered significant amounts for defrauded investors [1]